BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved BPC 157: Experimental Peptide Creates Risk for Athletes BPC 157 Benefits and Research Applications Stable Isotope Labeling Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC 157 in Doping Control by UHPLC HRMS